Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Clinical variables identify seronegative HCV co-infection in HIV-infected individuals.

Bharti AR, Letendre SL, Wolfson T, Clifford D, Collier AC, Gelman B, McArthur J, Marra C, McCutchan A, Morgello S, Simpson D, Ellis RJ, Grant I.

J Clin Virol. 2011 Dec;52(4):328-32. doi: 10.1016/j.jcv.2011.08.021. Epub 2011 Sep 15.

2.

Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.

Carrieri MP, Lions C, Sogni P, Winnock M, Roux P, Mora M, Bonnard P, Salmon D, Dabis F, Spire B; ANRS CO13 HEPAVIH Study Group.

J Hepatol. 2014 Jan;60(1):46-53. doi: 10.1016/j.jhep.2013.08.014. Epub 2013 Aug 24.

PMID:
23978720
3.

[A preliminary assessment of the clinical utility of measuring hepatitis C virus antibody to evaluate infection status].

Long L, Liu Y, Duan Z, Xu Q, Shen T, Dou X, Zhuang H, Lu F.

Zhonghua Gan Zang Bing Za Zhi. 2014 Apr;22(4):244-50. doi: 10.3760/cma.j.issn.1007-3418.2014.04.002. Chinese.

PMID:
25173220
4.

Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?

Rockstroh JK, Peters L, Grint D, Soriano V, Reiss P, Monforte Ad, Beniowski M, Losso MH, Kirk O, Kupfer B, Mocroft A; EuroSIDA in EuroCoord.

J Hepatol. 2013 Aug;59(2):213-20. doi: 10.1016/j.jhep.2013.04.005. Epub 2013 Apr 11.

PMID:
23583272
5.

Hepatitis C virus infection in the mothers and infants cohort study.

Granovsky MO, Minkoff HL, Tess BH, Waters D, Hatzakis A, Devoid DE, Landesman SH, Rubinstein A, Di Bisceglie AM, Goedert JJ.

Pediatrics. 1998 Aug;102(2 Pt 1):355-9.

PMID:
9685438
6.

Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients.

Torti C, Costarelli S, De Silvestri A, Quiros-Roldan E, Lapadula G, Cologni G, Paraninfo G, Castelnuovo F, Puoti M, Carosi G; BHCC Study Group.

Drug Saf. 2007;30(12):1161-9.

PMID:
18035868
7.

Screening for hepatitis C virus in human immunodeficiency virus-infected individuals.

Thio CL, Nolt KR, Astemborski J, Vlahov D, Nelson KE, Thomas DL.

J Clin Microbiol. 2000 Feb;38(2):575-7.

8.

Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS).

Frederick T, Burian P, Terrault N, Cohen M, Augenbraun M, Young M, Seaberg E, Justman J, Levine AM, Mack WJ, Kovacs A.

AIDS Patient Care STDS. 2009 Nov;23(11):915-23. doi: 10.1089/apc.2009.0111.

9.

Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.

Solomon SS, Mehta SH, Srikrishnan AK, Solomon S, McFall AM, Laeyendecker O, Celentano DD, Iqbal SH, Anand S, Vasudevan CK, Saravanan S, Lucas GM, Kumar MS, Sulkowski MS, Quinn TC.

Lancet Infect Dis. 2015 Jan;15(1):36-45. doi: 10.1016/S1473-3099(14)71045-X. Epub 2014 Dec 3.

10.

Prevalence of hepatitis C virus in alcoholic patients: role of parenteral risk factors.

Galperim B, Cheinquer H, Stein A, Fonseca A, Lunge V, Ikuta N.

Arq Gastroenterol. 2006 Apr-Jun;43(2):81-4.

11.

HIV and HCV co-infection: situation at six French university hospitals in the year 2000.

Buffet-Janvresse C, Peigue-Lafeuille H, Benichou J, Vabret A, Branger M, Trimoulet P, Goria O, Laurichesse H, Abbed A, Verdon R, Bouvet E, Lafon ME, Dussaix E, Cormerais L, Dupon M, Henquell C, Josse A, Lagoutte P, Lariven S, LeGac S, Riachi G, Verdon R, Vittecoq D; HIV-HCV Cohort Study Group.

J Med Virol. 2003 Jan;69(1):7-17.

PMID:
12436472
12.

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.

Nelson M, Amaya G, Clumeck N, Arns da Cunha C, Jayaweera D, Junod P, Li T, Tebas P, Stevens M, Buelens A, Vanveggel S, Boven K; ECHO and THRIVE Study Groups.

J Antimicrob Chemother. 2012 Aug;67(8):2020-8. doi: 10.1093/jac/dks130. Epub 2012 Apr 24.

13.

Characteristics of HCV co-infection among HIV infected individuals from an area with high risk of blood-borne infections in central China.

Zhang T, Tully DC, Zhou S, He N.

PLoS One. 2014 Apr 7;9(4):e94219. doi: 10.1371/journal.pone.0094219. eCollection 2014.

14.

Current practices of screening for incident hepatitis C virus (HCV) infection among HIV-infected, HCV-uninfected individuals in primary care.

Freiman JM, Huang W, White LF, Geng EH, Hurt CB, Taylor LE, Overton ET, Cachay ER, Kitahata MM, Moore RD, Rodriguez B, Mayer KH, Linas BP.

Clin Infect Dis. 2014 Dec 15;59(12):1686-93. doi: 10.1093/cid/ciu698. Epub 2014 Sep 3.

15.

Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests.

George SL, Gebhardt J, Klinzman D, Foster MB, Patrick KD, Schmidt WN, Alden B, Pfaller MA, Stapleton JT.

J Acquir Immune Defic Syndr. 2002 Oct 1;31(2):154-62.

PMID:
12394793
16.

The spectrum of undiagnosed hepatitis C virus infection in a US HIV clinic.

Taylor LE, Foont JA, DeLong AK, Wurcel A, Linas BP, Chapman S, Maynard MA, Cu-Uvin S, Mayer KH.

AIDS Patient Care STDS. 2014 Jan;28(1):4-9. doi: 10.1089/apc.2013.0130.

17.

Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.

Otegbayo JA, Taiwo BO, Akingbola TS, Odaibo GN, Adedapo KS, Penugonda S, Adewole IF, Olaleye DO, Murphy R, Kanki P.

Ann Hepatol. 2008 Apr-Jun;7(2):152-6.

PMID:
18626434
18.

Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients.

Charpentier C, Champenois K, Gervais A, Landman R, Joly V, Le Gac S, Larrouy L, Damond F, Brun-V├ęzinet F, Descamps D, Yazdanpanah Y.

PLoS One. 2013;8(3):e59205. doi: 10.1371/journal.pone.0059205. Epub 2013 Mar 19.

19.

Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus.

Bonacini M, Lin HJ, Hollinger FB.

J Acquir Immune Defic Syndr. 2001 Apr 1;26(4):340-4.

PMID:
11317075
20.

Active co-infection with HBV and/or HCV in South African HIV positive patients due for cancer therapy.

Musyoki AM, Msibi TL, Motswaledi MH, Selabe SG, Monokoane TS, Mphahlele MJ.

J Med Virol. 2015 Feb;87(2):213-21. doi: 10.1002/jmv.24055. Epub 2014 Aug 25.

PMID:
25156907

Supplemental Content

Support Center